|
Benign ovarian lesions
|
74
|
39 (52.7)
|
53 (71.6)
|
0.12, 1.81
|
1.22 ± 0.46
|
|
Serous cystadenoma
|
28
|
22 (78.6)
|
28 (100)
|
1.23, 1.81
|
1.52 ± 0.19
|
|
Mucinous cystadenoma
|
17
|
13 (76.5)
|
17 (100)
|
1.12, 1.79
|
1.48 ± 0.20
|
|
Fibrothecoma
|
18
|
3 (16.7)
|
3 (16.7)
|
0.40, 1.58
|
0.82 ± 0.44
|
|
Cystadenofibroma
|
6
|
0 (0)
|
0 (0)
|
0.12, 0.94
|
0.52 ± 0.26
|
|
Brenner tumor
|
5
|
1 (20)
|
5 (100)
|
0.88, 1.44
|
1.06 ± 0.23
|
|
Malignant ovarian lesions
|
128
|
108 (84.4)
|
128 (100)
|
0.56, 1.45
|
0.91 ± 0.20
|
|
Serous cystadenocarcinoma
|
35
|
26 (74.3)
|
35 (100)
|
0.66, 1.35
|
0.97 ± 0.20
|
|
Mucinous cystadenocarcinoma
|
27
|
20 (74.1)
|
20 (100)
|
0.65, 1.31
|
0.89 ± 0.19
|
|
Serous borderline tumor
|
12
|
10 (83.3)
|
10 (100)
|
0.78, 1.45
|
1.05 ± 0.19
|
|
Mucinous borderline tumor
|
9
|
8 (88.9)
|
9 (100)
|
0.75, 1.36
|
0.99 ± 0.17
|
|
Clear cell adenocarcinoma
|
8
|
8 (100)
|
8 (100)
|
0.69, 1.01
|
0.82 ± 0.13
|
|
Endometrioid adenocarconoma
|
6
|
6 (100)
|
6 (100)
|
0.71, 1.06
|
0.93 ± 0.11
|
|
Granulosa cell tumor
|
7
|
6 (85.7)
|
6 (100)
|
0.79, 1.33
|
0.98 ± 0.18
|
|
Undifferentiated adenocarcinoma
|
5
|
5 (100)
|
5 (100)
|
0.64, 1.19
|
0.83 ± 0.23
|
|
Metastatic tumors
|
19
|
19 (100)
|
19 (100)
|
0.56, 1.09
|
0.86 ± 0.15
|
